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Chromosomal passenger complex hydrodynamics 
suggests chaperoning of the inactive state by 
nucleoplasmin/nucleophosmin
ABSTRACT The chromosomal passenger complex (CPC) is a conserved, essential regulator of 
cell division. As such, significant anti–cancer drug development efforts have been focused on 
targeting it, most notably by inhibiting its AURKB kinase subunit. The CPC is activated by 
AURKB-catalyzed autophosphorylation on multiple subunits, but how this regulates CPC in-
teractions with other mitotic proteins remains unclear. We investigated the hydrodynamic 
behavior of the CPC in Xenopus laevis egg cytosol using sucrose gradient sedimentation and 
in HeLa cells using fluorescence correlation spectroscopy. We found that autophosphoryla-
tion of the CPC decreases its sedimentation coefficient in egg cytosol and increases its diffu-
sion coefficient in live cells, indicating a decrease in mass. Using immunoprecipitation coupled 
with mass spectrometry and immunoblots, we discovered that inactive, unphosphorylated 
CPC interacts with nucleophosmin/nucleoplasmin proteins, which are known to oligomerize 
into pentamers and decamers. Autophosphorylation of the CPC causes it to dissociate from 
nucleophosmin/nucleoplasmin. We propose that nucleophosmin/nucleoplasmin complexes 
serve as chaperones that negatively regulate the CPC and/or stabilize its inactive form, pre-
venting CPC autophosphorylation and recruitment to chromatin and microtubules in mitosis.
INTRODUCTION
The four-protein chromosomal passenger complex (CPC) is essen-
tial for proper cell division in many eukaryotes (Sampath et al., 
2004; Nguyen et al., 2014). Comprising one each of AuroraB kinase 
(AURKB), inner centromere protein (INCENP), borealin/DasraB 
(CDCA8), and survivin (BIRC5) subunits, the complex localizes to 
mitotic chromosomes during metaphase, where it is involved in 
chromosome condensation (Mackay et al., 1998) and the spindle 
assembly checkpoint (Tseng et al., 2010). During anaphase and cy-
tokinesis, the CPC redistributes to the midzone between microtu-
bule asters, where it assists in localizing the cleavage furrow and 
triggering its ingression (Cooke et al., 1987; Field et al., 2015).
The CPC and its individual subunits have been extensively stud-
ied both to understand their biological function and to investigate 
AURKB as a potential drug target for cancer treatment (Portella 
et al., 2011). AURKB is a critical mitotic kinase that phosphorylates 
many mitotic proteins (Carmena et al., 2012), including the CPC 
components INCENP (Adams et al., 2000; Bishop and Schumacher, 
2002; Honda et al., 2003; Sessa et al., 2005) and CDCA8 (Gassmann 
et al., 2004). AURKB also phosphorylates itself on Thr-232 within its 
activation loop (Yasui et al., 2004). Clustering the CPC on chromatin 
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Homo sapiens (ranging from 70% identical for AURKB to only 24% 
for CDCA8/9; see Materials and Methods), the overall architecture 
and regulation of the complex are highly conserved.
We report that the CPC hydrodynamic profile changes with au-
tophosphorylation regardless of cell cycle state. This change oc-
curs in both X. laevis extract and live mitotic HeLa cells and indi-
cates a decrease in native molecular weight upon activation. We 
then provide evidence for an interaction between the CPC in its 
inactive state and the nucleophosmin/nucleoplasmin (NPM) family 
of oligomeric histone chaperones. We propose that NPM com-
plexes are regulatory chaperones that stabilize the inactive state of 
the CPC.
RESULTS
CPC autophosphorylation causes a decrease 
in sedimentation coefficient
Human AURKB is controlled in part by autophosphorylation on 
T232 in its activation loop, which activates the kinase (Yasui et al., 
2004). To examine phosphoregulation of X. laevis AURKB and the 
CPC as a whole, we used a phosphatase inhibitor, okadaic acid, in 
combination with AURKB inhibitors (barasertib, ZM447439, and 
VX680, listed here from most to least specific) in a variety of applica-
tions. We first wanted to confirm that autophosphorylation of this 
site occurs in mitotic X. laevis HSS (clarified extract from eggs; 
Groen et al., 2011). We incubated HSS with AURKB inhibitors, oka-
daic acid, or sequential treatment with AURKB inhibitors, followed 
by okadaic acid. AURKB phosphosites will be blocked from phos-
phorylation by pretreatment with AURKB inhibitors, but all other 
phosphosites will become phosphorylated in response to okadaic 
acid. We performed immunoblot analysis of the treated extracts for 
pThr232-AURKB, and stathmin/Op18 (STMN), a known AURKB tar-
get that undergoes a gel shift upon phosphorylation (Gadea and 
Ruderman, 2006). The pThr232-AURKB antibody was raised to the 
activation-loop phosphosite in humans with high homology in 
X. laevis AURKA and AURKB (Figure 1A). As anticipated, okadaic 
acid addition promoted AURKB and STMN phosphorylation, as 
shown by a band shift in the latter protein (Figure 1B). These phos-
phorylations were blocked by pretreatment with AURKB inhibitors, 
indicating that AURKB and STMN phosphorylation requires AURKB 
activity in mitotic HSS. Diluting HSS before adding okadaic acid re-
duced AURKB phosphorylation (Supplemental Figure S2), suggest-
ing that two CPCs may interact to promote AURKB phosphorylation 
in-trans, which is consistent with prior reports (Kelly et al., 2007).
Using the drug treatments characterized in Figure 1B, we probed 
the hydrodynamic properties of the CPC in mitotic HSS as a function 
of its activity state. After drug treatment, we diluted HSS 1:1 in S-
CSF-XB-phosphate, fractionated it on 5–40% sucrose gradients, and 
blotted fractions with antibodies raised against X. laevis INCENP 
and CDCA9 (Figure 1C, top; Sampath et al., 2004). In all cases, 
INCENP and CDCA9 cofractionated, suggesting that the complex 
stays intact during centrifugation. There was no difference in sedi-
mentation between basal state of mitotic HSS and HSS preincu-
bated with barasertib, a highly specific AURKB inhibitor. However, 
when mitotic HSS was preincubated with okadaic acid, the CPC pro-
teins sedimented substantially higher up on the sucrose gradient 
(Figure 1C, second bracket from bottom). The shift in sedimentation 
coefficient (S-value) is similar to that previously observed based on 
bovine serum albumin (BSA; 4S) and bovine γ-globulin (7S) stan-
dards run on a parallel gradient (Bolton et al., 2002). This shift could 
be due to a decrease in mass upon phosphorylation or to a confor-
mational change to a more extended conformation with a higher 
frictional coefficient.
or microtubules or multimerizing it with antibodies triggers activat-
ing autophosphorylation of AURKB, suggesting that this occurs in-
trans (Kelly et al., 2007). In addition, AURKB phosphorylation of 
INCENP allosterically activates AURKB (Adams et al., 2000; Bishop 
and Schumacher, 2002; Honda et al., 2003; Sessa et al., 2005). De-
spite this progress, we lack full understanding of how the CPC is 
regulated by autophosphorylation.
Crystal structures of both termini of INCENP and its CPC binding 
partners have been obtained, but the structure of the entire com-
plex remains elusive (Sessa et al., 2005; Jeyaprakash et al., 2007; 
Sessa and Villa, 2014). The middle region of INCENP was previously 
believed to contain a coiled-coil domain, but recent evidence sug-
gests that this region may in fact be a single α-helix 32 nm long that 
is capable of stretching up to 80 nm, allowing CDCA8 and BIRC5 to 
anchor the complex while AURKB phosphorylates other proteins in 
the vicinity (Samejima et al., 2015). A long, single α-helix may be 
prone to degradation and might need to be stabilized when the 
complex is inactive. Inactive CPC is unphosphorylated on key resi-
dues of AURKB and INCENP, but whether posttranslational modifi-
cations or chaperone proteins assist in stabilizing the inactive state 
is unknown. Stabilization of an inactive state by these mechanisms 
is common in other kinases (Shalloway and Taylor, 1997), other cyto-
kinesis proteins (Staus et al., 2011), and other protein complexes 
(Berrabah et al., 2011; Koryakina et al., 2014).
Hydrodynamic measurements provide a classic approach to elu-
cidating regulatory mechanisms of protein complexes. Comparison 
of the CPC sedimentation coefficient in interphase and mitotic 
Xenopus laevis extracts revealed slower sedimentation rate in mito-
sis, which was attributed to cell cycle regulation (Bolton et al., 2002). 
However, in that study, the mitotic extract was treated with the phos-
phatase inhibitor microcystin and diluted into buffer containing ad-
ditional phosphatase inhibitors, whereas the interphase extract was 
not treated with phosphatase inhibitors at any step. Therefore the 
reported difference in sedimentation coefficient between mitotic 
and interphase CPC could have been caused by artificial induction 
of CPC autophosphorylation and activation in the mitotic sample 
rather than by the cell cycle state difference. Here we show that 
autophosphorylation does indeed determine CPC’s sedimentation 
coefficient in both mitosis and interphase, and we use the resulting 
hydrodynamic information to gain additional insights into how the 
CPC is regulated.
The X. laevis egg extract system is ideal for studying the CPC, as 
it is arrested in a mitotic state and contains a relatively high concen-
tration of CPC proteins (estimated between 55 and 155 nM, based 
on mass spectrometry of individual subunits; Wuhr et al., 2014). 
X. laevis has different maternally stored and embryonically ex-
pressed forms of CDCA8 and BIRC5; we will refer to the maternally 
stored forms analyzed in this work as CDCA9 (also known as DasraA) 
and BIRC5.1, respectively. Here we use high-speed supernatant 
(HSS) of X. laevis egg extract lacking glycogen or membranous or-
ganelles prepared such that the cell cycle state (mitotic or inter-
phase) was retained (Groen et al., 2011; Mitchison et al., 2013). In 
particular, a degradation-resistant form of cyclin B was added to the 
extract before the high-speed spin to stabilize the mitotic state of 
HSS without the use of phosphatase inhibitors. A major downside to 
the X. laevis extract system is its lack of genetic tractability, which 
makes tagging of endogenous proteins with green fluorescent pro-
tein (GFP) variants difficult. We therefore also investigated CPC be-
havior in mitotic HeLa cells, using the clustered regularly interspaced 
short palindromic repeats/Cas9 DNA endonuclease (CRISPR/Cas9) 
system to tag endogenous proteins with GFP (Cong et al., 2013). 
Although CPC protein sequences vary between the X. laevis and 
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in Figure 1C. The mitotic HSS used in Figure 
1 was prepared using methods that do not 
require phosphatase inhibitors to stabilize 
the mitotic state by adding recombinant cy-
clin B Δ90 to the crude extract before cen-
trifugation (Groen et al., 2011). To test the 
effect of cell cycle on CPC hydrodynamic 
behavior and AURKB phosphorylation, we 
prepared interphase HSS by first cycling 
crude mitotic extract into interphase with 
the addition of calcium and then preventing 
any further protein translation with the ad-
dition of cycloheximide before the centrifu-
gation step that transforms crude extract 
into HSS. To confirm the cell cycle state of 
mitotic and interphase HSS, we immuno-
blotted with an antibody against phosphory-
lated epitopes of mitotic protein 2 (MPM2) 
target sites, which are more abundant in 
mitosis (Figure 2A; Kuang et al., 1994; Field 
et al., 2014). Substantially less protein phos-
phorylated by MPM2 was recognized in the 
interphase than in the mitotic sample, 
showing that the cell cycle state had been 
maintained throughout the HSS prepara-
tion without the use of phosphatase inhibi-
tors. Similar to MPM2, band intensity ratios 
between interphase and mitotic crude ex-
tract were previously reported by Field 
et al. (2011) and are shown in Supplemental 
Figure S4A.
We repeated the sucrose gradient ex-
periments to probe the effects of kinase 
and phosphatase inhibitors on the CPC, 
comparing interphase and mitotic HSS pre-
pared from the same extract. Treatment 
with 1 μM okadaic acid was sufficient to 
shift mitotic CPC to the low-S form, but 10 
μM was required to shift interphase CPC 
(Figure 2, B and C). We therefore concluded 
that the basal state of the CPC is the same 
in both cell cycle states and can undergo 
similar phosphorylation-driven shifts to the 
lower-S form, although less phosphatase 
inhibition is required in mitosis. We next tested the levels of AURKB 
phosphorylation at Thr-232 in response to inhibitors (Figure 2D). 
Unsurprisingly, AURKB phosphorylation was promoted by okadaic 
acid and inhibited by barasertib in both cell cycle states. We con-
cluded that autophosphorylation drives the CPC to a lower S-value 
independent of cell cycle state.
We attempted to measure the Stokes radius of the native and 
phosphorylated CPC using gel filtration chromatography to com-
pare changes in size with the hydrodynamic behavior observed 
on sucrose gradients. However, during gel filtration in a wide 
range of buffers and on a wide range of resins, the CPC smeared 
out on the column. Blots of the fractions for CPC subunits sug-
gested that the complex dissociated, potentially in response to 
dilution or to nonspecific interactions with the resin. Similar re-
sults were seen in a previous study (Bolton et al., 2002). We there-
fore turned to a less perturbing method, fluorescence correlation 
spectroscopy (FCS), to further probe CPC hydrodynamics (see 
later description).
To test whether AURKB activity is necessary for the observed 
phosphorylation-induced hydrodynamic shift of the CPC, we 
used the same two-drug strategy as in Figure 1B, sequentially 
dosing with barasertib and okadaic acid, followed by sucrose 
gradient sedimentation. The CPC proteins had the same S-value 
as in the basal and AURKB-inhibited states (Figure 1C, bottom). 
Therefore AURKB activity is required to reduce the value of the 
sedimentation coefficient of the CPC in response to okadaic acid 
treatment.
CPC sedimentation behavior is not primarily regulated 
by the cell cycle state
Similar basal hydrodynamic properties of the CPC in X. laevis were 
previously reported, and a shift from high- to low-S form was at-
tributed to cell cycle regulation (Bolton et al., 2002). In those ex-
periments, a phosphatase inhibitor was added to mitotic but not 
interphase samples, so it is possible that the observed S-value 
shifts were instead due to phosphorylation effects, as we observed 
FIGURE 1: Phosphatase inhibition activates AURKB and causes a change in the hydrodynamic 
properties of its associated protein complex. (A) Sequences of the activation loop of human and 
X. laevis AURKB and X. laevis AURKA. Differences are highlighted in red, and the key 
phosphorylated threonine is highlighted in turquoise. (B) Mitotic HSS was incubated with kinase 
inhibitors and okadaic acid. Equal reaction volumes were run on an SDS–PAGE gel and 
immunoblotted with antibodies against pT232-AURK (which recognizes AURKA, AURKB, and 
AURKC phosphorylated at the conserved threonine on the activation loop of the kinase), STMN, 
and α-tubulin. The blot was quantified by normalizing pAURKB intensity to α-tubulin intensity 
and set such that the lowest value of each replicate was the DMSO control (lanes where no 
intensity could be detected are marked as zero). The p value between the DMSO and okadaic 
acid samples is 0.014; n = 3. (C) Mitotic HSS was incubated with kinase inhibitor or DMSO for 
25 min, followed by okadaic acid or DMSO for an additional 25 min. Equal volumes were 
sedimented on 5–40% sucrose gradients for 6 h at 237,000 × g and 4°C. The indicated fractions 
were separated on SDS–PAGE gels and immunoblotted with antibodies against INCENP and 
CDCA9. The identity of the higher–molecular weight band in higher-numbered INCENP blots is 
unknown but likely corresponds to a posttranslationally modified version of INCENP. Full blots 
with molecular weight markers are given in Supplemental Figure S1. (D) Sucrose gradient blots 
in C were quantified and normalized to the total amount of the indicated protein in the gradient. 
Error bars represent SD. The p values indicated by asterisks were calculated between the 
barasertib- and okadaic acid–treated samples in fractions 3 (INCENP 0.00046, CDCA9 0.0075) 
and 4 (INCENP 0.0057, CDCA9 0.0062); n = 4.
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treatment. A band of similar molecular 
weight to AURKA did show barasertib-sensi-
tive phosphorylation in X. laevis HSS (Figure 
1D). It is possible that barasertib is less spe-
cific in X. laevis. Alternatively, cross-phos-
phorylation of AURKA and AURKB may oc-
curs in HSS due to the lack of subcellular 
organization, or the upper band in HSS 
might in fact be a modified form of AURKB. 
No phosphorylated AURKB was observed in 
untreated HeLa cells (Supplemental Figure 
S5). In preliminary biochemical studies, we 
were unable to observe autophosphoryla-
tion of AURKB in response to phosphatase 
inhibition in HeLa cell lysates, potentially as 
a result of greater dilution in HeLa lysates 
than with X. laevis HSS. This prevented the 
use of sucrose gradients to measure hydro-
dynamic regulation of the CPC, and so in-
stead we used FCS to obtain hydrodynamic 
information in live cells.
FCS measures the movement of fluo-
rescent molecules in and out of a small 
illuminated volume and thus measures diffu-
sion coefficients in live cells (Kim et al., 
2007).  FCS requires a cell line in which the 
CPC is fluorescently tagged but with mini-
mal artifacts resulting from overexpression 
of a single CPC subunit. Ideally, tagged cells 
should also have a high fluorescence signal 
per particle to maximize detection but a low 
concentration of tagged particles to facili-
tate measurement of intensity fluctuations. 
We tagged the C-terminus of the CDCA8 
subunit in HeLa cells with a GFP-3xFLAG 
tag using a CRISPR/Cas9 strategy (Cong et al., 2013) and sorted 
GFP-positive cells with FACS to obtain a cell line with stable expres-
sion. The concentration of tagged CDCA8 was too low to be de-
tected in blots of whole-cell lysates; however, when the 3xFLAG tag 
was immunoprecipitated from both the tagged cell line and the par-
ent line and blotted with an antibody against FLAG, only the tagged 
cell line exhibited a clear band at the expected molecular weight (62 
kDa), without any other significant bands (Figure 3B). Similarly, im-
munoprecipitation of the FLAG tag or random immunoglobulin G 
(IgG) from whole-cell lysates of the tagged cell line followed by an 
anti-FLAG blot showed a protein band at 62 kDa only in the FLAG 
IP, indicating that the tagging was successful (Figure 3C). We also 
obtained HeLa cell lines expressing GFP-tagged INCENP and 
CDCA8 from bacterial artificial chromosome (BAC) constructs as a 
generous gift from Tony Hyman (MPI Dresden, Germany; Poser 
et al., 2008). These express the tagged subunit from its endogenous 
promoter, but this expression occurs in addition to endogenous 
gene expression. Cell populations from each of the three cell types 
were fixed with paraformaldehyde and imaged by confocal micros-
copy (Figure 3D). All three lines showed the expected localization 
of the tagged CPC subunit to centromeres during metaphase and 
to midzone microtubules during anaphase/cytokinesis. The new 
CDCA8-GFP-3xFLAG CRISPR cell line exhibited significantly less 
background fluorescence than the BAC cell lines and had no ex-
pression in interphase cells, suggesting that a larger fraction of the 
tagged subunit was successfully incorporated into the CPC. We 
therefore selected the CRISPR-tagged line for FCS experiments.
Activation of soluble CPC causes faster diffusion 
in live HeLa cells
We next investigated whether hydrodynamic regulation of the CPC 
also occurs in human cells. To test whether CPC autophosphoryla-
tion can be triggered by okadaic acid in HeLa cells, we synchronized 
cells in mitosis by overnight treatment with the kinesin-5 inhibitor 
S-trityl-l-cysteine (STLC; Hu et al., 2012). This arrests cells in mono-
polar mitosis while minimally perturbing microtubule dynamics. We 
then incubated with barasertib, okadaic acid, or both drugs concur-
rently and lysed cells with SDS–PAGE running buffer. We then blot-
ted with the antibody against pThr232-AURKB used previously 
(Figure 3A). Mitotic cells treated with barasertib had minimal phos-
phorylated AURKB. Phosphatase inhibition by okadaic acid in-
creased AURKB phosphorylation levels, which was counteracted by 
pretreatment with barasertib. These effects are similar to those ob-
served in X. laevis HSS and suggest that similar autophosphoryla-
tion regulates CPC kinase activity across organisms. Phosphatase 
inhibition also increased phosphorylation of two bands whose mole-
cular weights suggested they are AURKA and AURKC. The se-
quence recognized by the antibody to phosphor-AUKRB is similar in 
these homologues. Only AURKB and AURKC phosphorylation was 
blocked by cotreatment of the AURKB inhibitor. This suggests that 
AURKC (not present in X. laevis) activity may also be dependent on 
AURKB activity or that AURKC may also be inhibited by barasertib, 
which has not been tested (Mortlock et al., 2007). Phosphorylation 
levels of AURKA, on the other hand, were not affected by barasertib 
FIGURE 2: CPC hydrodynamic properties are similar in interphase and mitotic HSS. 
(A) Interphase HSS was prepared by cycling CSF X. laevis egg extract into interphase with 
calcium and then adding cycloheximide, followed by the high-speed spin. Equal amounts of 
interphase and mitotic HSS prepared from the same extract were blotted with an MPM2 (mitotic 
phosphoprotein monoclonal) antibody that recognizes many CDK1 phosphosites more prevalent 
in mitosis (Kuang et al., 1994; Field et al., 2014). Interphase extract was prepared more than five 
times and compared with mitotic HSS prepared from the same crude extract using MPM2 blots 
twice. (B) Sucrose gradients were run as in Figure 1. Mitotic and interphase HSS were prepared 
from the same extract. Fractions were immunoblotted with antibodies raised against INCENP 
and CDCA9 after SDS–PAGE. Full blots with molecular weight markers are given in 
Supplemental Figure S3. (C) Sucrose gradient blots from B were quantified as in Figure 1D. Error 
bars represent SD; n = 2. For fraction 4, significant p values comparing basal interphase HSS and 
interphase HSS dosed with 1 and 10 μM okadaic acid (OA) were calculated to be 0.011 (INCENP, 
1 μM OA), 0.050 (INCENP, 10 μM OA), and 0.014 (CDCA9, 10 μM OA); n = 2–5. (D) Mitotic and 
interphase HSS samples prepared from the same extract were incubated with the indicated 
drugs as in Figure 1. The reactions were then blotted with antibodies against pT232-AURKB and 
α-tubulin, and pAURKB levels were quantified by normalizing to α-tubulin; n = 2.
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each population (Gslow and Gfast). We found 
that adding nocodazole to prevent astral 
microtubules from moving into the FCS 
voxel strongly reduced noise in autocorrela-
tion graphs, and so we added nocodazole 
to all subsequent experiments. Nocodazole 
did not appear to affect the hydrodynamics 
of the soluble pool of CPC. The diffusion co-
efficient of the fast-diffusing population was 
roughly three times lower than that of mo-
nomeric GFP (Kuhn et al., 2011) and is 
therefore likely the monomeric GFP-tagged 
CDCA8 outside of the CPC. The slow popu-
lation, therefore, is presumed to be the 
complete CPC. Given large uncertainties in 
size-dependent viscosity in live cells, we did 
not attempt to calculate a hydrodynamic ra-
dius of the large complex.
With a live-cell hydrodynamic assay in 
hand, we added AURKB kinase (barasertib) 
and phosphatase (okadaic acid) inhibitors to 
test the effect of autophosphorylation on dif-
fusion rates of the CPC. There was no sys-
tematic effect of okadaic acid or both drugs 
combined on Gslow/Gfast, suggesting the 
drugs did not cause dissociation of the CPC 
into its subunits (Figure 4B). Dfast exhibited 
no systematic changes in response to drugs, 
suggesting that unincorporated CDCA8 
does not undergo hydrodynamic changes 
alone in response to phosphorylation (Figure 
4C, right). However, Dslow, presumably cor-
responding to the diffusion constant of the 
native CPC, exhibited a time-dependent in-
crease in response to okadaic acid, indicat-
ing that the complex diffuses faster as it 
becomes phosphorylated (Figure 4C, left, 
green squares). When barasertib was added 
in addition to okadaic acid, no increase in dif-
fusion coefficient was observed, indicating 
the okadaic acid–induced change was due 
to autophosphorylation and requires AURKB 
activity (Figure 4C, left, red triangles).
We believe that the okadaic acid–induced, barasertib-inhibited 
increase in CPC diffusion rate measured by FCS is due to the same 
biochemistry as the okadaic acid–induced, barasertib inhibited de-
crease of the sedimentation coefficient of the CPC. An increase in 
diffusion coefficient upon phosphorylation is not consistent with an 
increased frictional coefficient of the complex and instead implies a 
shift to a lower molecular weight. Autophosphorylation could cause 
the CPC to shift to a lower molecular weight for two reasons: when 
inactive, the CPC could either be oligomerized or be bound to 
some large, unknown factor. The FCS data allow us to distinguish 
between these possibilities. Gslow/Gfast is equivalent to the ratio of 
fluorescent particles in each population multiplied by the ratio of 
the brightness of each population squared. If dephosphorylated 
CPC is an oligomer, then, in that state, one oligomer would contain 
multiple units of CDCA8-GFP but would only contribute one count 
to Gslow. On dissociation due to autophosphorylation, the apparent 
number of particles in the slow fraction would increase because 
each CPC containing one CDCA8-GFP subunit would be counted. 
The brightness of each particle in the slow fraction would decrease 
To measure the diffusion of GFP-tagged CDCA8 in live mitotic 
cells, we applied two-photon confocal FCS using previously de-
scribed methods (Needleman et al., 2009). Mitotic cells were identi-
fied in unsynchronized cells by morphology. Conventional two-pho-
ton confocal imaging before FCS revealed CPC localization to 
centromeres as in Figure 3D. We then focused the FCS beam away 
from chromatin and other static bodies that might affect the mea-
surement. Owing to the rapid time scales probed, FCS provides in-
formation only on the soluble pool of CPC. Representative primary 
FCS data presented as autocorrelation curves are shown in Figure 
4A (top). The red and blue lines are the best fit to either one-or two-
component models over multiple autocorrelation measurements. A 
model with a single diffusing species did not fit the data, whereas a 
two-species model gave a good fit in all cases (Figure 4A). An ex-
ample of low residuals with this fit is shown in Figure 4A (bottom, 
blue line). The two-component model assumes two distinct popula-
tions undergoing normal diffusion (Kim et al., 2007) with four fitting 
parameters: the two diffusion coefficients of each population (Dslow 
and Dfast) and the amplitudes of the autocorrelation functions of 
FIGURE 3: Tagging of CDCA8 in HeLa cells with GFP-3xFLAG. (A) HeLa cells were arrested in 
mitosis by overnight treatment with STLC and collected via mitotic shake-off, followed by 
washing with PBS. The indicated drugs were added to the final wash of the cells, after which the 
cells were lysed with freeze–thaw cycles. Cell lysates were then immunoblotted for pT232-AURK 
(recognizing pAURKA, pAURKB, and pAURKC) and α-tubulin. The p value between the 
barasertib- and okadaic acid–treated cells is 0.069; n = 2. (B) Lysates of the parent and tagged 
cell line were prepared as in A. Magnetic beads preloaded with an antibody against FLAG were 
used to immunoprecipitate (IP) tagged proteins from the lysates, and the resulting proteins 
were blotted for FLAG after separation via SDS–PAGE gel electrophoresis; n = 2. (C) Lysates of 
the tagged cell line were prepared as in A, and IPs were done with beads loaded with antibodies 
against random IgG or FLAG, followed by blotting for FLAG as in A; n = 2. (D) HeLa cells 
expressing GFP-tagged CPC were fixed with 4% paraformaldehyde, stained with an antibody 
against tubulin, and imaged with a spinning-disk confocal microscope at 60× magnification. 
Scale bars, 10 μm. Cells were imaged on three separate occasions.
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immunoprecipitated INCENP and CDCA9 
and subjected the samples to quantitative 
mass spectrometry analysis. We used tan-
dem mass tags (TMT) after proteolysis to dif-
ferentially label samples. Samples were 
pooled and analyzed using multinotch MS3 
methods to quantify the amount of each 
peptide that came from each sample (Wuhr 
et al., 2014). We ranked proteins by their en-
richment in immunoprecipitates (IPs) with 
AURKB inhibition over AURKB activation 
(Supplemental Table S1). Attractive candi-
dates had to meet two additional criteria: 
first, that they are abundant enough in frog 
eggs to bind all the CPC molecules, and 
second, that they have a large native mole-
cular weight, sufficient to affect CPC hydro-
dynamic properties through binding. When 
these criteria were applied, the nucleoplas-
min/nucleophosmin family of proteins 
(NPM) gave clear hits (Figure 5A). Similar 
results were seen in IP-MS experiments 
done in crude extract, for which we com-
pared IPs without drug, where complex acti-
vation is induced by clustering on beads, 
and in the presence of ZM447439, an 
AURKB inhibitor (Supplemental Table S2). 
In addition to being highly enriched in IPs 
of CPC under inactive versus activating con-
ditions, NPM family members are known 
to assemble into large homo- and hetero-
pentameric and -decameric complexes, 
which function as molecular chaperones 
(Namboodiri et al., 2004; Platonova et al., 
2011). They are also abundant in frog eggs. 
We observed peptides from both NPM2 
and nucleoplasmin 3 in IP-MS experiments 
but not from the somatic isoform NPM1, 
which is not expressed in eggs. NPM2 is an 
embryonic isoform that is highly abundant 
in X. laevis eggs (∼2000 nM), more than 
enough to sequester all of the CPC in the 
egg (∼100 nM; Wuhr et al., 2014). NPM3, 
which is much less abundant in eggs than 
NPM2 (∼150 nM), likely hetero-oligomerizes 
with NPM2, and so it is not clear whether it 
interacts independently with the CPC. Other 
proteins that were identified as potential CPC inactive-state binding 
partners through IP-MS include partitioning defective 3 homologue 
(PARD3), a protein involved in asymmetrical cell division, and the 
chromatin protein chromobox protein homologue 3. These were 
less reproducible interactions than with NPMs 2 and 3 than in previ-
ous experiments in crude extract (Supplemental Table S2), the pro-
teins are less abundant in eggs, and their native molecular weight is 
uncharacterized. We therefore focused on NPMs.
We next used IP-immunoblots from mitotic HSS to retest the 
IP-MS findings. Immunoprecipitations of random IgG, INCENP, 
CDCA9, and NPM2 from HSS dosed with no drug, barasertib, oka-
daic acid, or barasertib followed by okadaic acid were blotted with 
antibodies against INCENP and NPM2. We observed very strong 
interaction between both CPC components and NPM2 under 
AURKB-inhibited conditions but no interaction when phosphatases 
by the same ratio. Therefore, when cells are treated with okadaic 
acid, Gslow would decrease, and Gslow/Gfast would decrease corre-
spondingly. However, Gslow/Gfast did not change, regardless of drug 
treatment (Figure 4B). This suggests an absence of phosphoregu-
lated oligomerization. Therefore the observed changes in hydrody-
namic properties of the CPC are more likely due to its binding to 
some other large factor(s) when inactive, and this complex dissoci-
ates upon autophosphorylation.
Inactive CPC interacts with nucleoplasmin/nucleophosmin 
oligomers
To identify candidate inactive CPC-binding proteins, we returned to 
X. laevis, using an immunoprecipitation–mass spectrometry (IP-MS) 
strategy in both HSS and crude extract. Mitotic HSS was treated 
with barasertib, okadaic acid, or both drugs as in Figure 1B. We then 
FIGURE 4: Fluorescence correlation spectroscopy of HeLa CDCA8-GFP-3xFLAG cells. Mitotic 
cells were identified and CPC localization to centrosomes confirmed by conventional imaging. 
The FCS measurement beam was directed into the cytoplasm near the edge of cells away from 
chromosomes to report on soluble CPC diffusion. (A) Example autocorrelation curves (top; black 
circles represent averages, and red and blue lines represent the fitted one- and two-component 
FCS models, respectively) and weighted residuals (bottom). (B) Ratio of amplitudes of slow- to 
fast-diffusing populations over time after drug treatment. Amplitudes are proportional to the 
number of molecules in a focal volume and molecular brightness squared. (C) Diffusion 
coefficients over time after drug treatment of the slow (left) and fast (right) populations in the 
presence of 1 μM nocodazole, with no further drug treatment (blue circles), or after treatment 
with only 250 nM okadaic acid (OA; green squares) or with both 250 nM OA and 250 nM 
barasertib (BA; red triangles). Each data point represents one mitotic cell, identified by 
observing round cell morphology and chromosomes in phase contrast, and averages were 
obtained by taking multiple measurements in each cell at each time point. Error bars represent 
the SD of the fitted parameters of the nonlinear regression.
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were inhibited and AURKB is active (Figure 
5B). The only exception was the immuno-
precipitation of INCENP without any drugs. 
In this case, low levels of NPM2 were ob-
served (much lower than in the barasertib-
inhibited cases). We suspect that this is 
because the well-known AURKB-activating 
properties of the antibody raised against 
INCENP cause this sample to behave more 
like the okadaic acid–treated sample (Kelly 
et al., 2007). We repeated the IP-immunob-
lot experiments in crude extract, which is 
arrested in mitosis, and extract induced to 
enter interphase by addition of calcium. As 
in HSS, NPM2 was strongly present in IPs of 
the CPC when the complex was inactive 
(barasertib treatment) but not when it was 
active (no treatment or treated with oka-
daic acid; Figure 5C). This result was similar 
in mitotic and interphase crude extract 
(Figure 5C).
To test the strength of the interaction be-
tween the CPC and NPM2, we immunopre-
cipitated the CPC using the antibody 
against CDCA9. We then subjected the 
beads to increasing concentrations of salt 
for brief periods and analyzed the amount 
of NPM2 dislodged from the beads (Figure 
5D). We found that although substantial 
amounts of NPM2 were removed in the ini-
tial wash and lowest salt concentration, a 
population of NPM2 remained attached to 
the beads even at high salt concentrations. 
In fact, NPM2 was only completely removed 
from the beads at concentrations when the 
CPC itself starts to dissociate, as identified 
by the presence of INCENP in the washes at 
300 and 500 mM KCl. This was not the case 
with another highly abundant protein, actin, 
which is not known to interact directly with 
the CPC. Actin was effectively removed by 
the initial low-salt washes, and very little re-
mained at higher salt concentrations. This 
experiment suggests a fairly tight interac-
tion between NPM2 and the CPC, although 
FIGURE 5: NPM2 interacts with inactive CPC. (A) CPC proteins were immunoprecipitated from 
mitotic HSS and analyzed via quantitative mass spectrometry. Protein counts were normalized to 
IgG IPs and the target protein (INCENP or CDCA9). Ratios for each protein were generated by 
dividing reporter ion counts from barasertib-treated samples by counts from okadaic acid–
treated samples. Proteins with a ratio >1 (gridlines on plot) indicate enrichment in barasertib-
treated samples over okadaic acid–treated samples. Labeled proteins are those with ratios >1 in 
both CDCA8 and INCENP IPs. Size of bubbles is proportional to the measured amount of 
protein in X. laevis extract (Wuhr et al., 2014). Full lists of proteins and ratios are given in 
Supplemental Table S1. (B) Mitotic HSS was incubated with barasertib (BA), okadaic acid (OA), 
both, or neither as in Figure 1. Beads loaded with antibodies against X. laevis INCENP, CDCA9, 
and NPM2 were used for immunoprecipitations from treated mitotic HSS, and then the proteins 
on the beads were blotted with antibodies against INCENP and NPM2. Blots were quantified by 
dividing levels of the blotted protein by levels of the IP target protein. Fold change represents 
change in NPM2 levels (INCENP and CDCA9 IPs) or INCENP levels (NPM2 IP) after intensities 
were normalized by setting the DMSO lane to 1. Values of 0 indicate no detectable intensity. 
The p values between the BA and OA samples indicated by the asterisk are 0.029 (CDCA9 IP) 
and 0.043 (NPM2 IP); n = 2. Full blots, including molecular weight markers, are given in 
Supplemental Figure S6. (C) Crude X. laevis extract was cycled into interphase with the addition 
of calcium, and both mitotic and interphase extract were treated with drugs as in B. Beads 
loaded with antibody against CDCA9 were used for immunoprecipitation and immunoblotted 
for INCENP and NPM2. NPM2 blots were quantified as described, normalized to INCENP, and 
with the lane treated with both drugs set to 1. Full blot including molecular weight markers is 
given in Supplemental Figure S7. (D) The CPC was immunoprecipitated from mitotic HSS using 
the antibody raised against CDCA9. After four quick low-salt washes, beads were incubated in 
solutions of increasing salt for 5 min each. The proteins bound to the beads before and after the 
salt washes, as well as those in the entire volume of each salt wash, were separated via SDS–
PAGE and protein levels analyzed by immunoblots of INCENP, NPM2, and actin. Protein levels 
were quantified as a percentage of the total of that protein. Error bars represent the SD; n = 2. 
Full blots including molecular weight markers are given in Supplemental Figure S8. (E) Sucrose 
gradients of barasertib (BA)- or okadaic acid (OA)–treated mitotic HSS were run as in Figure 1, 
except that fractions were one-third smaller. Every other fraction was immunoblotted for NPM2, 
INCENP, or CDCA9. NPM2 blots had 7.5 times less total protein concentration in each lane. 
NPM2 blots were quantified as in Figure 1. 
Error bars represent SD; n = 2. Full blots 
including molecular weight markers are given 
in Supplemental Figure S9. (F) Proposed 
model for phosphorylation-induced CPC 
hydrodynamic changes (CPC proteins: 
AURKB green, INCENP black line, CDCA8/9 
orange, BIRC5 yellow). Pentameric or 
decameric NPM oligomers (blue) interact 
with the CPC when the CPC is inactive and 
unphosphorylated. This interaction may 
involve direct binding or be mediated by 
other proteins. When phosphatases are 
inhibited, NPMs dissociate and the CPC is 
activated.
Volume 28 June 1, 2017 Inactive CPC interacts with NPMs | 1451 
cycle state, in both crude extracts and high-speed supernatants, 
and that this association is lost when the CPC autophosphophory-
lates in all cases (Figure 5, B and C). We attempted to perform simi-
lar experiments in HeLa cell lysates probing for NPM1, the somatic 
orthologue of NPM2. Our results were inconclusive, possibly due to 
the higher dilution in HeLa lysates. However, we suspect that inac-
tive CPC binds to NMP1 in cells to account for the increase in diffu-
sion constant we observed after autophosphorylation (Figure 4). 
Summarizing, we propose that inactive CPC is chaperoned by NPM 
complexes (Figure 5F).
Our model for stabilization of inactive CPC by a chaperone-like 
factor has precedent; other kinases complex with nonkinase pro-
teins that stabilize the inactive state. For example, in the inactive 
form of Src kinase, the kinase domain complexes with SH2 and SH3 
domains in the same polypeptide, which helps keep the kinase inac-
tive (Shalloway and Taylor, 1997). In general, the biochemistry of the 
inactive state of kinases deserves more experimental attention.
NPM family members exist as either highly disordered mono-
mers or assemble into pentameric and decameric oligomers (Scaloni 
et al., 2009, 2010; Duan-Porter et al., 2014; Mitrea et al., 2014), with 
well-established chaperone activity; indeed, the term “molecular 
chaperone” was first coined in 1978 by Laskey to describe the his-
tone chaperone activity of nucleoplasmin (Laskey et al., 1978; 
Gadad et al., 2011). The formation of oligomers, required for his-
tone chaperoning, is enhanced during mitosis, possibly by phos-
phorylation by cyclin/cyclin-dependent kinase (CDK) complexes (Lin 
et al., 2016). NPM1 protects a number of different proteins from 
aggregation during thermal denaturation (Szebeni and Olson, 
1999), despite having amyloid-like assembly properties itself (Di Na-
tale et al., 2015; Russo et al., 2017), and escorts ribosomal subunits 
and other proteins from the nucleus to the cytoplasm (Maggi et al., 
2008; Mitrea et al., 2016), binds RNA (Sagawa et al., 2011; Hisaoka 
et al., 2014) and G-quadruplex DNA (Federici et al., 2010; Gallo 
et al., 2012; Banuelos et al., 2013; Chiarella et al., 2013; Arcovito 
et al., 2014; Scognamiglio et al., 2014), helps repair DNA damage 
(Koike et al., 2010), and assists in activating key mitotic kinases at 
the centrosome (Reboutier et al., 2012). NPM1 is also a phosphory-
lation target of AURKB, PLK1, and other kinases (So et al., 2012; 
Shandilya et al., 2014). Both NPM1 and NPM2 are highly posttrans-
lationally modified (Haindl et al., 2008; Neo et al., 2015; Okuwaki, 
2008; Wilczek et al., 2011) and bind histones H2A and H2B (Gadad 
et al., 2011; Fernandez-Rivero et al., 2016; Okuwaki et al., 2001). 
NPM2 is particularly abundant in X. laevis eggs and is believed to 
sequester H2A and H2B (Onikubo et al., 2015), to catalyze their as-
sembly into chromatin and assist in transcription repression before 
the midblastula transition through histone sequestration (Laskey 
et al., 1978; Platonova et al., 2011; Finn et al., 2012; Bouleau et al., 
2014) and may be involved in the decondensation of sperm chro-
matin (Burns et al., 2003; Inoue et al., 2011; Okuwaki et al., 2012).
We can imagine several reasons that inactive CPC might be 
chaperoned by NPM complexes. Most obviously, this may prevent 
inactive CPC from competing with active CPC for binding to AURKB 
targets such as chromatin and microtubules. It may also slow auto-
activation of the CPC. The CPC functions in a highly dynamic sys-
tem, where its inactive and active forms rapidly interconvert, leading 
to local gradients in substrate phosphorylation on a micrometer 
scale (Afonso et al., 2014). NPM sequestration of the inactive state 
may assist in tuning this delicate balance. NPM interactions may 
also catalyze nucleus–cytoplasm trafficking of the CPC; during inter-
phase, NPMs are substrates for nuclear import through the Ran-
KPNB1 (importin) system (Quensel et al., 2004) and interact with 
exportin, ultimately localizing to nucleoli (Bolli et al., 2007). 
we cannot formally distinguish direct binding from binding via ad-
ditional proteins.
To test possible relevance of NPM2 complexes in the phospho-
regulated sedimentation behavior of the CPC observed in Figures 1 
and 2, we performed sucrose gradient analysis of X. laevis mitotic 
HSS treated with barasertib or okadaic acid and blotted for CPC and 
NPM2 subunits (Figure 5E). The major NPM2 peak sedimented at 
approximately 8S as previously reported, reflecting its pentameric or 
decameric structure (Laskey et al., 1978). The fastest-sedimenting 
tail of the NPM2 peak cosedimented with inactive, fast-sedimenting 
CPC in barasertib-treated HSS, consistent with a model in which in-
active CPC is complexed to NPM2 oligomers. In okadaic acid–
treated HSS, both CPC subunits shifted to a slower-sedimenting 
peak as before, but the NPM2 sedimentation profile was largely un-
changed, although NPM2 in the okadaic acid–treated sample seems 
to have a slightly lower sedimentation coefficient. Free NPM2 should 
have a lower sedimentation coefficient than NPM2 complexed with 
the CPC. However, NPM2 is approximately 20 times more abundant 
in the egg than CPC proteins, and the expected sedimentation 
change of NPM2 complexed with the CPC could be largely masked 
by the ∼95% of NPM2 that does not interact with the CPC. We also 
examined the sedimentation pattern of histone H2A, because NPM2 
is a known histone chaperone, but saw no apparent change be-
tween different drug treatments (Supplemental Figure S9)
Although not the focus of our analysis, our IP-MS data also re-
vealed candidate proteins that interact more with active than with 
inactive CPC (Supplemental Table 1, with ratios in Figure 5A of <1). 
These included Kif20A, a kinesin that is believed to transport CPC 
toward microtubule plus ends during cytokinesis (Nguyen et al., 
2014). Further experimentation is required to evaluate the signifi-
cance of these proteins.
DISCUSSION
We used a combination of nonspecific phosphatase inhibitor and 
specific kinase inhibitors to confirm previous studies showing that 
the CPC can be activated by autophosphorylation, most likely in-
trans (Yasui et al., 2004; Kelly et al., 2007). We then investigated the 
effect of autophosphorylation on hydrodynamic behavior of the 
CPC in HSS from X. laevis eggs and live HeLa cells. We confirmed 
that the CPC can undergo a regulated change in hydrodynamic be-
havior, using sucrose gradient sedimentation (Figure 1). By compar-
ing CPC sedimentation in mitotic and interphase HSS prepared 
without the use of phosphatase inhibitors (Figure 2), we showed that 
the decrease in S-value was triggered by autophosphorylation and 
not by cell cycle regulation as previously proposed (Bolton et al., 
2002). Using FCS to measure the diffusion of CPC in live HeLa cells, 
we found that autophosphorylation caused an increase in diffusion 
constant (Figure 4C). Combining the decrease in S-value observed 
by sucrose gradient sedimentation and the increase in diffusion co-
efficient observed by FCS upon treatment with a phosphatase in-
hibitor, we concluded that autophosphorylation caused a decrease 
in native molecular weight. This change was not due to reversal of 
an oligomeric state, because we observed no increase in the con-
centration of low–molecular weight CPC relative to unincorporated 
CDCA8 by FCS when the CPC was autophosphorylated (Figure 4B). 
The most likely explanation of these data is that inactive CPC is in 
complex with some large but diffusible particle, and autophosphor-
ylation promotes disassembly of this complex. By IP-MS in egg ex-
tract, we identified a strong candidate for the CPC binding partner: 
the abundant oligomeric histone chaperone nucleophosmin (NPM2; 
Figure 5A). By reciprocal IP-Western blot, we confirmed that inac-
tive CPC associates with NPM2 in egg extracts, regardless of cell 
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generous gift of David Shetcher (Albert Einstein College of Medi-
cine). Antibodies were purchased from commercial sources for 
pThr232-AURKB (2914S; Cell Signaling), MPM2 (16-155; Millipore), 
BIRC5 (2808S; Cell Signaling), FLAG (2368P; Cell Signaling), α-
tubulin (T6199; Sigma-Aldrich), actin (MAB1501R; Fisher), histone 
H2A.Z (2718; Cell Signaling), random rabbit IgG (011-000-003; 
Jackson ImmunoResearch), goat anti-mouse DyLight 680 conju-
gated (35518; Thermo), goat anti-rabbit DyLight 800 conjugated 
(35571; Thermo), and Alexa Fluor 568 goat anti-mouse (A-11004; 
Life Technologies).
Western blots
Protein solutions were diluted in sample buffer (5×: 200 mM Tris-
HCl, pH 6.8, 20% glycerol, 25% β-mercaptoethanol, 100 mg/ml 
SDS, 0.5 mg/ml bromophenol blue [Fluka]) and heated at 85–90°C 
for 5 (pAURKB blots) or 10 min (all other blots). The solutions were 
then separated on 4–12% NuPAGE Bis-Tris gels (Life Technologies) 
in MES buffer (Life Technologies). After gel electrophoresis, proteins 
were transferred to a nitrocellulose membrane (0.2 μm; Bio-Rad) or 
polyvinylidene fluoride membrane (0.2 μm, histone blots only; Bio-
Rad) via wet transfer in 25 mM Tris base, 30 mM glycine, and 20% 
methanol buffer at 100 V for 2 h or 35 mA for 12–16 h at 4°C. Mem-
branes were stained with Ponceau S stain (0.5% [wt/vol] Ponceau S 
[Mallinckrodt], 1% acetic acid [JT Baker]) before cutting the mem-
brane into strips for analysis with multiple antibodies (if necessary). 
Membranes were blocked with Odyssey Blocking Buffer (phos-
phate-buffered saline [PBS]; LI-COR) for 1 h at room temperature or 
overnight at 4°C. Membranes were incubated with primary and sec-
ondary antibodies for 1 h at room temperature. Primary antibodies 
were used at 1:1000 (commercial) or 1 μg/ml (produced in-lab), and 
secondary antibodies were used at 1:10,000. Between the primary 
and secondary antibodies and after the secondary antibody, mem-
branes were washed briefly with TBST (50 mM Trizma base, pH 7.6, 
155 mM NaCl, 1% Tween 20), followed by TBST and two rounds of 
TBS (50 mM Trizma base, pH 7.6, 155 mM NaCl) for 10 min each at 
room temperature. Membranes were imaged with an Odyssey Infra-
red Imager (LI-COR), adjusting intensity of illumination to just below 
the oversaturation point. Blots were quantified using the gel analysis 
tools in ImageJ and plotted using Microsoft Excel. The SDs were 
also calculated in Microsoft Excel. The p values were calculated us-
ing one-sided t tests in Excel and marked by asterisks on the figures.
Homology analysis
Sequences of X. laevis and human CPC subunits were obtained 
from the UniProt database and compared using the NCBI BLAST 
tool, reporting the percentage identical.
X. laevis crude extract and HSS preparation
Mitotic HSS was prepared as previously described (Groen et al., 
2011). Standard protocols for the use of female X. laevis to obtain 
eggs by hormonal injection were approved by the Harvard Medical 
Area Standing Committee on Animals. S-CSF-XB-phosphate buffer 
(10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid [HEPES], 
pH 7.7, 100 mM KCl, 5 mM ethylene glycol tetraacetic acid [EGTA], 
1 mM MgCl2, 1 mM ATP, 1 mM GTP, 1 mM dithiothreitol, 5 mM 
glucose-6-phosphate, 1 mM creatine phosphate) was used for any 
dilutions. Interphase HSS was prepared as mitotic HSS, with the ad-
dition of cycling crude extract into interphase with calcium (Field 
et al., 2014) and adding 2 μg/ml cyclohexamide before the hard spin. 
HSS was aliquoted, frozen in liquid nitrogen, and stored at −80°C 
until use. All HSS used in this work was mitotic unless otherwise indi-
cated. Crude extract was used immediately after preparation.
Nucleus–cytoplasm shuttling of the CPC is probably important in 
prophase regulation of chromatin and the nuclear envelope, and 
there are hints that the CPC is involved in nuclear pore reformation 
late in cytokinesis (Afonso et al., 2014) and that the CPC phosphory-
lates nuclear proteins during mitosis (Dhanasekaran et al., 2016). 
NPM also reportedly has important roles in mitosis; disrupting the 
protein with (+)-avrainvillamide, a small molecule that binds NPM1, 
results in supernumerary chromosomes (Mukherjee et al., 2015). 
This may be a result of disrupting its inhibition of the CPC, although 
direct action of this abundant protein in mitotic progression is also a 
plausible explanation.
We suspect that NPMs bind the CPC near the AURKB subunit 
near the C-terminus of INCENP, for a few reasons. To have inhibitory 
function on AURKB, it is much more likely to be bound at or near the 
kinase in the complex. Second, the antibody against INCENP was 
raised from a C-terminal peptide, and this antibody is known to turn 
on AURKB activity (Kelly et al., 2007). It may do this by knocking off 
inhibitory NPMs. Genetic analysis of the function of the CPC-NPM 
interaction will be challenging because both are essential for cell 
growth (Cutts et al., 1999; Burns et al., 2003; Grisendi et al., 2005). 
Progress will likely depend on precise mapping, followed by muta-
tion, of regions involved in the interaction. Depletion of NPM2 
might be feasible in egg extract, although its abundance and the 
high likelihood that depleting NPM2 would codeplete CPC present 
significant experimental challenges.
The exact nature of the CPC-NPM interaction remains to be un-
derstood. We did not observe histones enriched in IPs of inactive 
CPC by MS or by Western blot, suggesting that binding of CPC and 
H2A/H2B to NPM2 might be mutually exclusive, but this point re-
quires further investigation. It is also whether NPM2 or a protein that 
mediates the NPM2-CPC interaction recognizes some structural 
characteristic of the CPC present only when AURKB is inactive or 
whether NPM2 actually holds it in an inactive state. We also do not 
know the full extent of phosphorylation of CPC subunits or NPM 
family members by AURKB. In particular, the phosphorylation state 
of NPM may guide oligomerization, known to be important in other 
NPM chaperone functions. Finally, it is possible that other proteins 
that coimmunoprecipitate with inactive CPC, such as PARD3, play a 
role in NPM-CPC interactions, either by mediating the interaction 
itself or by adding additional functionality. Understanding the mech-
anistic implications of the NPM-CPC relationship will provide addi-
tional insight into cell division as a whole and potentially establish 
new proteins as drug targets for modulating cell division. Finally, our 
work extends the idea of NPM complexes as chaperones to a new 
substrate, the CPC. It will be interesting to ask what other substrates 
are chaperoned by NPM members in vivo and whether chaperone 
activity plays a role in the function of NPM1 mutants as oncogenes 
in acute myeloid leukemia (Bolli et al., 2007).
MATERIALS AND METHODS
General
Experiments were repeated with at least two biological replicates 
unless otherwise indicated.
Materials
All chemicals were purchased from Sigma-Aldrich unless otherwise 
noted.
Antibodies
Antibodies against X. laevis INCENP and CDCA8 were raised 
against C-terminal peptides as previously described (Kelly et al., 
2007; Ozlu et al., 2010). The antibody against X. laevis NPM2 was a 
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sequences in Phusion high-fidelity PCR master mix with HF buffer 
using the program 1) 94°C, 2 min, 2) 94°C, 30 s, 3) 54°C, 30 s, 
4) 72°C, 2 min, 5) repeat steps 2–4 nine more times, 6) 94°C, 30 s, 
7) 72°C, 2 min, 8) repeat steps 6 and 7 24 more times, and 9) 72°C, 
10 min. Cut backbone and PCR products were purified on 1% aga-
rose (Lonza) gels in TAE buffer (40 mM Tris base, 1 mM EDTA, 5.7% 
acetic acid), followed by DNA isolation using the QIAquick Gel Ex-
traction kit (Qiagen) according to the manufacturer’s instructions. 
Backbone (3 μl) and inserts (1 μl each) were combined and annealed 
together at 50°C for 30 min in 15-μl isothermal assembly buffer 
(Gibson et al., 2009). The reaction was then transformed into 5-al-
pha competent Escherichia coli (high efficiency; NEB) according to 
the manufacturer’s instructions. Cloning was confirmed by sequenc-
ing using a T7 reverse primer (Genewiz). HeLa cells (24 × 104 per 
well of a six-well plate [Corning]) were transfected simultaneously 
with the two plasmids using Lipofectamine 3000 (Life Technologies) 
according to the manufacturer’s instructions (2 μg of donor DNA, 1 
μg of guide/Cas9 pX330 DNA, 3.75 μg of Lipofectamine 3000, and 
6 μl of P3000). Cells were then selected by FACS using a BD FAC-
SAria IIu-3 Laser with a 488-nm laser. All guides produced fluores-
cent cells with proper localization of GFP to the midzone in mitosis 
(see Confocal microscopy). The population with the most cells after 
FACS sorting from the first guide sequence listed was used for sub-
sequent experiments.
Confocal microscopy
Cells were grown on glass coverslips (22 × 22 mm, no. 1.5; VWR), 
fixed with 4% paraformaldehyde in PBS (Corning) for 15 min at 
room temperature, permeabilized with 0.2% Triton X-100 in PBS 
(PBST) for 20 min at room temperature, and immunostained with 
antibodies against α-tubulin (1:400 in PBST, 1 h, room temperature) 
and Alexa Fluor 568 goat anti-mouse (1:400 in PBST, 1 h, room tem-
perature), followed by three 5-min washes in PBST. The coverslips 
were then placed onto 10-μl droplets of 10% glycerol in PBST on 
clean coverslips and sealed with Valap (1:1:1 lanolin, paraffin [Fluka], 
and petroleum jelly). Images were obtained at the Nikon Imaging 
Center at Harvard Medical School at room temperature using a 60× 
oil Plan Apo 1.49 numerical aperture (NA) objective lens (Nikon) on 
a confocal Nikon Ti motorized inverted microscope equipped with a 
Yokogawa CSU-X1 spinning disk (Spectral Applied Research Aurora 
Borealis modification), Perfect Focus, a Prior Proscan II motorized 
stage, a Spectral Applied Research LMM-5 laser merge module 
(excitation:emission 488:480/40, 561:620/60, 642:700/75) with 
acousto-optical tunable filter–controlled solid-state lasers, and a 
Hamamatsu ORCA-AG cooled charge-coupled device camera, 
driven by MetaMorph. Images were prepared for publication using 
ImageJ. No modifications were made to images beyond minor 
brightness and contrast adjustments and cropping to center images 
on mitotic cells.
Fluorescence correlation spectroscopy
FCS measurements were performed on a Nikon Eclipse Ti micro-
scope using two-photon excitation from a Ti:Sapphire pulsed laser 
(Mai-Tai; Spectral-Physics) with 80-MHz repetition rate and ∼70-fs 
pulse width at 920-nm wavelength. The excitation light was ex-
panded and collimated to fully utilize the numerical aperture of the 
water immersion objective (CFI Apo 40 × WI, NA 1.25; Nikon) that 
focuses the light into the sample. The intensity of excitation light was 
modulated to 3 mW at the objective by a combination of half-wave 
plate and polarizing beam splitter (Thorlab). Cells were grown to 
80–90% confluency on glass coverslips with #1.5 thickness, 25 mm 
diameter, and poly-d-lysine coating (Neuvitro). During imaging, we 
HeLa cell culture and lysate preparation
HeLa cells were cultured in DMEM (Corning), 10% fetal bovine se-
rum (Life Technologies), and 1% 100× penicillin/streptomycin solu-
tion (Corning) at 37°C, 5% CO2, and 85% relative humidity. Mitotic 
HeLa lysates were prepared by dosing cells at ∼70–80% confluency 
for 16 h with 3 μM STLC and then isolating mitotic cells via vigorous 
shake-off. The mitotic cells were washed three times with cold PBS 
(Corning) supplemented with STLC. After the removal of the final 
wash, protease inhibitors (leupeptin, pepstatin A, and chymostatin, 
10 μg each as a 10 mg/ml mixture of all three in dimethyl sulfoxide 
[DMSO]), cytochalasin D (10 μg from a 10 mg/ml solution in DMSO), 
and nocodazole (7.5 μg as a 25 mM solution in DMSO) were added 
to the pellet, which was subsequently frozen in liquid nitrogen and 
thawed at room temperature three times to lyse cells. The lysate was 
then spun at 20,000 × g for 30 min at 4°C and the supernatant im-
mediately used in experiments. For cells treated with okadaic acid 
(1 μM; Enzo) or barasertib (1 μM; ApexBio), the drug was added to 
the final wash of the cells and also just before lysis after removal of 
the final PBS wash.
Sucrose gradients
For each gradient (5–40% [wt/wt] in S-CSF-XB-phosphate), five step 
gradients (5, 14, 23, 32, and 40% sucrose) of equal volume (950 μl) 
were gently layered, highest density on the bottom, by pipetting 
into ½ × 2 inch ultraclear centrifuge tubes (Beckman Coulter) and 
allowed to diffuse overnight at 4°C into a continuous gradient. A 
50-μl amount of HSS was treated with DMSO, barasertib, okadaic 
acid, or a combination of drugs (barasertib followed by okadaic 
acid) for 25 min per drug at room temperature before being diluted 
in half with S-CSF-XB-phosphate and pipetted gently onto the su-
crose gradient. The sucrose gradients were then spun in tandem at 
237,000 × g for 6 h at 4°C in an SW55Ti rotor (Beckman Coulter). 
Gradients were fractionated from the top by pipetting 130 μl (Figure 
5) or 400 μl (Figures 1 and 2), and fractions 2–8 of 12 total fractions 
(Figures 1 and 2) and every other fraction from 3 to 21 of 36 total 
fractions were blotted for INCENP, CDCA9, and NPM2. BSA (4S) 
and bovine γ-globulin (7S) standards were run on parallel gradients 
and their fractionation determined by SDS–PAGE gel electrophore-
sis of all fractions, followed by staining with Coomassie blue (45% 
methanol [BDH], 10% glacial acetic acid [JT Baker], 0.25 g of Coo-
massie blue [Fluka]) and destaining with an aqueous solution of 
7.5% acetic acid and 20% methanol.
Tagging of CDCA8-GFP-3xFLAG in HeLa cells
Guide RNA to cut at the C-terminal endogenous locus of CDCA8 in 
HeLa cells was designed using the tools at crispr.mit.edu. The top 
five hits were selected, and oligos (CACCGAATGAGACACCAAA-
GTTGAC, CACCGAGACACCAAAGTTGACAGGA, CACCGCAAC-
TTTGGTGTCTCATTTG, CACCGAACTTTGGTGTCTCATTTGT, and 
CACCGAAAGTCCATCCTGTCAACTT and reverse complements 
[IDT]) to generate guide RNAs were cloned into the pX330-U6-Chi-
meric_BB-CBh-hSpCas9 plasmid (Addgene) following the deposit-
ing lab’s instructions at crispr.genome-engineering.org (Cong et al., 
2013). Successful cloning was confirmed by sequencing using a U6 
sequencing primer (Genewiz). Donor DNA was generated via iso-
thermal assembly (Gibson et al., 2009) of two Geneblocks (IDT) and 
a modified pET21a(+) backbone (Novagen) with a 650–base pair 
homology arm on the N-terminal side of the insert and a 597–base 
pair homology arm on the C-terminal side of the insert. The back-
bone was cut using EcoRI and ZraI restriction enzymes (NEB) for 2 h 
at 37°C. The Geneblocks were amplified in PCRs using oligos with 
30–base pair overlaps with the backbone and 20–base pair priming 
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Immunoprecipitations were performed as described. The beads 
were taken up in 5 μl of 8 M guanidine-HCl, incubated at 60°C for 
20 min, and diluted to 2 M guanidine-HCl with 20 mM N-(2-hy-
droxyethyl)piperazine-N′-(4-butanesulfonic acid) (HEPBS), pH 9.0. 
A 0.4-μl amount of 2 mg/ml LysC (Wako Chemical) was added and 
incubated at room temperature for 14 h. The slurry was then di-
luted again to 0.5 M guanidine-HCl with the same HEPBS solution, 
and an additional 0.4 μl of 2 mg/ml LysC was added along with 
0.8 μl or 0.5 mg/ml trypsin (Promega sequencing grade), and the 
solution was incubated at 37°C for 8 h. After transfer to a fresh 
tube, the supernatant was removed by vacuum overnight. The pel-
lets were diluted in 20 μl of 300 mM HEPES, pH 8.0, and 3 μl of 
TMT (Thermo). Dry acetonitrile at 5 mg/250 μl was added to the 
solution, which was then incubated at room temperature for 2 h. A 
3-μl amount of 5% hydroxylamine (99.999% pure; Sigma-Aldrich) 
was added, followed by a 15-min room temperature incubation, 
after which the solvent was removed by vacuum overnight. The 
solution was acidified to pH ∼1 with phosphoric acid, and a C18 
stage-tip was done to desalt the sample (Rappsilber et al., 2007). 
All solvent was removed, and the sample was resuspended in 6 μl 
of 1% formic acid. A 3-μl amount of the sample was shot on an 
Orbitrap Lumos instrument as previously reported (Wuhr et al., 
2015). Samples were normalized by IgG IPs and by the amount of 
target protein (INCENP or CDCA8). The normalized amount of 
protein in the barasertib-treated sample was divided by that in the 
okadaic acid–treated sample, and hits were considered to be 
those proteins that had values >1.
Salt elution assay
The antibody against CDCA9 was used to immunoprecipitate the 
CPC from 100 μl of mitotic HSS as described and washed with the 
same buffer as before briefly four times. Half of the beads were 
isolated. The other half was subjected to five washes of 15-μl wash 
buffers for 5 min on ice per wash. The salt concentration was in-
creased from 25 mM KCl to 100, 150, 300, and finally 500 mM KCl, 
removing each wash before adding the next one. A 5-μl amount of 
sample buffer was added to each wash. Bead aliquots from both 
before and after the washes were resuspended in 15 μl of sample 
buffer. The beads and washes were analyzed by SDS–PAGE, fol-
lowed by immunoblotting as described.
used a home-built temperature-controlled chamber to maintain cells 
at 37°C in an imaging medium, FluoroBrite DMEM (Life Technolo-
gies) supplemented with 10 mM HEPES and 2 mM l-glutamine, cov-
ered with mineral oil. A hybrid detector (HPM-100-40; Becker & 
Hickl) with 510/42 bandpass filter (Chroma) and TCSPC module 
(SPC-150; Becker & Hickl) were used to collect GFP fluorescence and 
calculate the normalized autocorrelation function of the fluorescence 
intensity fluctuations.
Contraction assays
X. laevis crude mitotic and interphase extract were prepared as 
described. Droplets of extract (1 μl) were carefully placed in a plas-
tic Petri dish containing mineral oil (Field et al., 2011). Drops were 
side-illuminated with light (LED Spotlight; AmScope) and imaged 
with a dissecting scope (Leica MZFLIII) fitted with a PLANAPO 
1.0× objective and an 18.0 monochrome without infrared camera 
(Diagnostic Instruments) and MetaMorph. Images were processed 
using ImageJ.
FCS data analysis
Each autocorrelation function was collected for 10 s while the excita-
tion beam was parked close to the edge of a mitotic cell. From 20 
to 50 autocorrelation functions were averaged after the outliers 
were removed. The following two-component FCS model was fitted 
to the average autocorrelation function:
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where Gi and τD,i are the amplitude and diffusion time of each com-
ponent, respectively, and S is the ratio between the equatorial (wxy) 
and axial (wz) radii of the focal volume. Before every FCS experi-
ment, wxy and wz were determined from the FCS measurements on 
calibration samples, 9.7 and 97 nM Alexa 488 dye in water, assum-
ing that the diffusion coefficient of Alexa 488 is 435 μm2/s (Petrasek 
and Schwille, 2008). The nonlinear fitting was performed by a MAT-
LAB built-in function, nlinfit, with the observation weight specified 
to the inverse of the SD of the autocorrelation functions. The diffu-
sion time, τD,i, was converted into the diffusion coefficient, Di, using 
the relationship
D
w
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Immunoprecipitation
Anti-FLAG M2 beads or Dynabeads Protein A beads (Life Technolo-
gies), charged with INCENP, CDCA9, NPM1, and NPM2 antibody at 
saturating levels according to the manufacturer’s instructions, were 
incubated end over end with lysate, crude X. laevis egg extract, or 
HSS after drug treatment for at least 45 min at 4°C. Beads were 
separated from the lysate on a DynaMag-2 Magnet (Life Technolo-
gies) and washed with cold 10 mM HEPES, 1 mM MgCl2, 25 mM 
KCl, 1 mM EGTA, and 0.01% Tween 20, pH 7.7, at least four times 
and subjected to immunoblot analysis or quantitative mass spec-
trometry (Tween 20 omitted for mass spectrometry experiments). 
For immunoprecipitations from crude extract, cytochalasin D was 
omitted from the extract preparation (Field et al., 2014) to permit 
contraction assays (described later). Cytochalasin D was then added 
to the extract along with other drugs for the immunoprecipitation.
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